Aetna Inc (AET) Position Trimmed by Rehmann Capital Advisory Group

Rehmann Capital Advisory Group decreased its position in shares of Aetna Inc (NYSE:AET) by 5.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,424 shares of the company’s stock after selling 263 shares during the quarter. Rehmann Capital Advisory Group’s holdings in Aetna were worth $897,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AET. Migdal Insurance & Financial Holdings Ltd. lifted its holdings in shares of Aetna by 3,076.7% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 953 shares of the company’s stock worth $175,000 after acquiring an additional 923 shares during the last quarter. Fiera Capital Corp bought a new position in shares of Aetna in the second quarter worth about $217,000. Jennison Associates LLC lifted its holdings in shares of Aetna by 2.1% in the second quarter. Jennison Associates LLC now owns 243,407 shares of the company’s stock worth $44,665,000 after acquiring an additional 4,903 shares during the last quarter. Sei Investments Co. lifted its holdings in shares of Aetna by 2.8% in the second quarter. Sei Investments Co. now owns 224,644 shares of the company’s stock worth $41,223,000 after acquiring an additional 6,163 shares during the last quarter. Finally, FineMark National Bank & Trust bought a new position in shares of Aetna in the second quarter worth about $219,000. 82.34% of the stock is owned by institutional investors and hedge funds.

A number of research analysts have recently commented on AET shares. Zacks Investment Research reissued a “buy” rating and issued a $224.00 target price on shares of Aetna in a report on Monday, November 12th. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $204.00 price objective on shares of Aetna in a research note on Tuesday, October 30th. Citigroup upped their price objective on Aetna from $202.00 to $206.00 and gave the company a “neutral” rating in a research note on Wednesday, October 31st. Credit Suisse Group lowered their price objective on Aetna from $207.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, October 31st. Finally, Piper Jaffray Companies downgraded Aetna from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $212.00 to $206.00 in a research note on Tuesday, October 30th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $207.33.

Aetna stock opened at $212.70 on Friday. Aetna Inc has a 1 year low of $166.88 and a 1 year high of $213.36. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.79 and a quick ratio of 0.79. The company has a market capitalization of $69.64 billion, a PE ratio of 21.57, a PEG ratio of 1.82 and a beta of 0.71.

Aetna (NYSE:AET) last released its earnings results on Tuesday, October 30th. The company reported $2.96 earnings per share for the quarter, beating analysts’ consensus estimates of $2.83 by $0.13. The business had revenue of $15.48 billion during the quarter, compared to the consensus estimate of $15.40 billion. Aetna had a net margin of 5.99% and a return on equity of 20.78%. The company’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.45 EPS. On average, sell-side analysts predict that Aetna Inc will post 11.38 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.com-unik.info/2018/12/08/aetna-inc-aet-position-trimmed-by-rehmann-capital-advisory-group.html.

Aetna Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Recommended Story: What are trading strategies for the 52-week high/low?

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit